The Utility of Drug Challenge Testing in Brugada Syndrome: a Systematic Review and Meta-analysis
Pattara Rattanawong, MD1,2, Jakrin Kewcharoen, MD3, Chanavuth Kanitsoraphan, MD3, Wasawat Vutthikraivit, MD4 , Prapaipan Puttapiban, MD5, Narut Prasitlumkum, MD3, Poemlarp Mekraksakit, MD4, Raktham Mekrittikrai, MD3, Eugene H Chung MD6
1) Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ, USA
2) Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
3) University of Hawaii Internal Medicine Residency Program, Honolulu, HI, USA
4) Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA
5) Department of Medicine, Einstein Medical Center, Philadelphia, PA, USA.
6) Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, Michigan
Running head: Drug challenge testing in Brugada syndrome
Word count : 3,274
Financial Support : This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Declaration of Interest : None